Hochschulschrift
Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Stuttgart, Universität Stuttgart, Dissertation, 2017
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Stuttgart
- (who)
-
Universitätsbibliothek der Universität Stuttgart
- (when)
-
2017
- Creator
- Contributor
-
Olayioye, Monilola
- DOI
-
10.18419/opus-9128
- URN
-
urn:nbn:de:bsz:93-opus-ds-91455
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Möller, Yvonne
- Olayioye, Monilola
- Universitätsbibliothek der Universität Stuttgart
Time of origin
- 2017
Other Objects (12)
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer
Target Mutant KRAS with Molecular Glue
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
A pan-KRAS degrader for the treatment of KRAS-mutant cancers
Current therapy of KRAS-mutant lung cancer
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer
Target Mutant KRAS with Molecular Glue
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
A pan-KRAS degrader for the treatment of KRAS-mutant cancers
Current therapy of KRAS-mutant lung cancer
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer
Target Mutant KRAS with Molecular Glue
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
A pan-KRAS degrader for the treatment of KRAS-mutant cancers
Current therapy of KRAS-mutant lung cancer